BioSpace News Archive

Business

Roche Cuts 165 Jobs in New Jersey, Scales Back COVID-19 Portfolio

The layoffs will go into effect on July 25, according to a Worker Adjustment and Retraining Act (WARN) notice filed in April.

May 10, 2023
·
2 min read
·
Rosemary Scott
FDA

FDA Approves Fabry Disease Treatment from Chiesi, Protalix

Elfabrio’s label contains a boxed warning for hypersensitivity reactions, such as anaphylaxis, and recommends that medical support measures should be on standby when administering the treatment.

May 10, 2023
·
2 min read
·
Tristan Manalac
What You Need to Know to Launch a Biotech Startup

More and more life science professionals are weighing a leap from working in the corporate world to launching a company of their own. Here are some points they should know.

May 10, 2023
·
4 min read
·
Joanna Smiley
Policy

Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup

The biopharma company scored two major wins on Tuesday: a court victory over HIV patent claims and an acquisition deal to expand its pipeline in cancer and inflammatory diseases.

May 10, 2023
·
2 min read
·
Tristan Manalac
Business

Will Advancements in AI Lead to Job Loss in Biotech?

The biotechnology industry may not suffer as many losses as other industries due to generative AI, but the future of the job market is still uncertain for some.

May 10, 2023
·
3 min read
·
Natalia Mesa
Policy

Update: FDA Delays Decision on Sarepta’s DMD Gene Therapy

The FDA set a new action date of June 22 for Sarepta’s gene therapy for the neuromuscular disease, approximately three weeks after the original date of May 29.

May 10, 2023
·
6 min read
·
Heather McKenzie
Drug Development

Therapies for Rare Mitochondrial Diseases Begin to See Traction

The approval of Reata Pharmaceuticals’ Skyclarys for Friedreich’s ataxia highlights progress being made in the treatment of rare mitochondrial diseases.

May 10, 2023
·
7 min read
·
Heather McKenzie
Business

Amgen Drops Drug Delivery Partnership, Targets Crohn’s Disease with TScan Pact

The biotech company shuffled deals around Tuesday, dropping a four-year collaboration with Israel’s Entera Bio and picking a new partner in Massachusetts-based TScan Therapeutics.

May 10, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Companies Bank on Psychedelics as Treatments for Mental Health Disorders

Developers of psychedelics-based therapies say the industry is poised to explode, with several reporting strong clinical trial results and the FDA granting breakthrough status for two hallucinogenic drugs.

May 10, 2023
·
6 min read
·
Joanna Smiley
Deals

Sobi Expands Hematology Portfolio with $1.7B Buy of CTI

The acquisition provides the Swedish company with an approved JAK inhibitor for myelofibrosis, a rare bone marrow cancer that disrupts the body’s normal production of blood cells.

May 10, 2023
·
2 min read
·
Kate Goodwin